Thomas Hallam BS, PhD, MBA

Dr. Hallam brings a broad base of pharmaceutical expertise, having led virtually every stage of pre-clinical research and clinical development. Prior to joining Leading BioSciences, he served as Director of Therapeutic Programs and Head of New Product Development for Mesoblast Inc., directing commercialization strategy and product development of adult stem cell products.
Dr. Hallam is a former Howard Hughes Medical Institute Research fellow. He received his Ph.D. in neuroscience from University California, Davis and holds an MBA from University of Southern California.